The device received FDA clearance last October and is the first modular lumbar interbody device with an open-face allowing in situ graft placement. The device also offers tactile feedback with face plate attachment and device placement flush with anterior aspect of the vertebrae.
The device is designed to meet surgeon requirements across a wide spectrum of patient anatomy. The company will begin the national rollout of the VisuALIF in March.
Read the release on VisuALIF by SpineSmith.
Read other coverage on orthopedic and spine devices:
– Integra LifeSciences Launches Integra Allograft Cancellous Sponge
– ConforMIS Receives FDA Approval for iTotal Patient-Specific Total Knee Replacement System
– B. Braun Announces FDA Approval of OTC Wound Management Gel
